| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Pushkal Garg | EVP Chief R&D | Mar 04, 2026 | Sale | $323.08 | 2,309 | 745,984 | 23,300 | Mar 06, 2026, 04:13 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Pushkal Garg | EVP Chief R&D | Mar 05, 2026 | Sale | $323.96 | 2,404 | 778,812 | 20,443 | Mar 06, 2026, 04:13 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Pushkal Garg | EVP Chief R&D | Mar 02, 2026 | Sale | $327.66 | 1,717 | 562,585 | 26,848 | Mar 04, 2026, 07:31 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Pushkal Garg | EVP Chief R&D | Mar 03, 2026 | Sale | $319.74 | 1,775 | 567,546 | 24,826 | Mar 04, 2026, 07:31 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Pushkal Garg | EVP Chief R&D | Feb 27, 2026 | Sale | $331.34 | 4,627 | 1,533,100 | 26,629 | Mar 02, 2026, 04:08 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Pushkal Garg | EVP Chief R&D | Feb 27, 2026 | Option/RSU Exercise | - | 1,908 | - | 26,756 | Mar 02, 2026, 04:08 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Pushkal Garg | EVP Chief R&D | Feb 13, 2026 | Sale | $310.08 | 2,242 | 695,201 | 24,848 | Feb 17, 2026, 07:28 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Pushkal Garg | EVP Chief R&D | Jan 12, 2026 | Sale | $362.87 | 1,510 | 547,929 | 23,982 | Jan 14, 2026, 04:23 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Pushkal Garg | EVP Chief R&D | Oct 02, 2025 | Sale | $452.05 | 2,937 | 1,327,675 | 26,065 | Oct 03, 2025, 05:12 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Pushkal Garg | EVP Chief R&D | Oct 03, 2025 | Sale | $451.48 | 3,022 | 1,364,387 | 22,561 | Oct 03, 2025, 05:12 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Pushkal Garg | EVP Chief R&D | Aug 19, 2025 | Sale | $458.41 | 1,455 | 666,987 | 21,400 | Aug 19, 2025, 05:28 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Pushkal Garg | EVP Chief R&D | Aug 18, 2025 | Sale | $453.27 | 1,396 | 632,759 | 23,033 | Aug 19, 2025, 05:28 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Pushkal Garg | CMO & EVP Dev & Med Affairs | Mar 21, 2025 | Sale | $285.00 | 4,321 | 1,231,485 | 20,221 | Mar 25, 2025, 04:10 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Pushkal Garg | CMO & EVP Dev & Med Affairs | Mar 24, 2025 | Option/RSU Exercise | $42.22 | 5,445 | 229,888 | 25,666 | Mar 25, 2025, 04:10 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Pushkal Garg | CMO & EVP Dev & Med Affairs | Mar 24, 2025 | Sale | $300.00 | 5,445 | 1,633,500 | 20,221 | Mar 25, 2025, 04:10 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Pushkal Garg | CMO & EVP Dev & Med Affairs | Feb 28, 2025 | Sale | $241.69 | 935 | 225,977 | 13,846 | Mar 03, 2025, 04:31 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Pushkal Garg | CMO & EVP Dev & Med Affairs | Feb 27, 2025 | Option/RSU Exercise | - | 1,908 | - | 13,897 | Mar 03, 2025, 04:31 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Pushkal Garg | CMO & EVP Dev & Med Affairs | Feb 14, 2025 | Sale | $255.17 | 1,561 | 398,325 | 14,749 | Feb 18, 2025, 04:47 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Pushkal Garg | CMO & EVP Dev & Med Affairs | Feb 18, 2025 | Sale | $251.67 | 1,548 | 389,579 | 12,675 | Feb 18, 2025, 04:47 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Pushkal Garg | CMO & EVP Dev & Med Affairs | Jan 27, 2025 | Option/RSU Exercise | $88.95 | 48,876 | 4,347,520 | 64,581 | Jan 29, 2025, 04:03 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Pushkal Garg | CMO & EVP Dev & Med Affairs | Jan 27, 2025 | Sale | $285.00 | 52,592 | 14,988,720 | 11,989 | Jan 29, 2025, 04:03 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Pushkal Garg | CMO & EVP Dev & Med Affairs | Dec 12, 2024 | Sale | $251.00 | 1,752 | 439,760 | 17,336 | Dec 13, 2024, 04:13 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Pushkal Garg | CMO & EVP Dev & Med Affairs | Nov 26, 2024 | Sale | $250.98 | 1,682 | 422,144 | 19,109 | Nov 27, 2024, 05:22 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Pushkal Garg | CMO & EVP Dev & Med Affairs | Jun 25, 2024 | Sale | $230.99 | 2,103 | 485,773 | 17,634 | Jun 26, 2024, 04:28 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Pushkal Garg | CMO & EVP Dev & Med Affairs | Feb 27, 2024 | Option/RSU Exercise | - | 1,908 | - | 9,240 | Feb 29, 2024, 04:17 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Pushkal Garg | CMO & EVP Dev & Med Affairs | Feb 28, 2024 | Sale | $155.30 | 574 | 89,145 | 8,993 | Feb 29, 2024, 04:17 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Pushkal Garg | CMO & EVP Dev & Med Affairs | Feb 16, 2024 | Sale | $148.06 | 1,308 | 193,666 | 8,160 | Feb 20, 2024, 04:09 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Pushkal Garg | CMO & EVP Dev & Med Affairs | Aug 04, 2023 | Sale | $185.85 | 3,461 | 643,223 | 11,314 | Aug 07, 2023, 06:05 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Pushkal Garg | CMO & EVP Dev & Med Affairs | Aug 07, 2023 | Sale | $183.89 | 4,166 | 766,083 | 5,399 | Aug 07, 2023, 06:05 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Pushkal Garg | CMO & EVP Dev & Med Affairs | Apr 27, 2023 | Sale | $194.59 | 1,839 | 357,855 | 8,488 | Apr 28, 2023, 05:54 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Pushkal Garg | CMO & EVP Dev & Med Affairs | Apr 28, 2023 | Sale | $199.02 | 2,455 | 488,595 | 6,596 | Apr 28, 2023, 05:54 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Pushkal Garg | CMO & EVP Dev & Med Affairs | Mar 03, 2023 | Sale | $200.00 | 18,072 | 3,614,400 | 4,345 | Mar 07, 2023, 04:07 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Pushkal Garg | CMO & EVP Dev & Med Affairs | Mar 03, 2023 | Option/RSU Exercise | $96.45 | 5,000 | 482,250 | 22,417 | Mar 07, 2023, 04:07 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Pushkal Garg | CMO & EVP Dev & Med Affairs | Aug 04, 2022 | Tax Payment (Shares) | $191.55 | 5,086 | 974,201 | 17,900 | Aug 05, 2022, 04:14 PM |
